Spain (ES)

Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework (2024) Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, et al. Journal article, Review article Pediatric kidney transplantation in Europe, a clinical snapshot pilot (2024) Oomen L, Bootsma-Robroeks CM, Bouts AH, Carbonell Pradas M, Gander R, Kienzl-Wagner K, König P, et al. Journal article Electronic and Structural Property Comparison of Iridium-Based OER Nanocatalysts Enabled by Operando Ir L3-Edge X-ray Absorption Spectroscopy (2024) van der Merwe M, Wibowo RE, Jimenez CE, Escudero C, Agostini G, Bär M, Garcia-Diez R Journal article Investigations of Crucial Factors for the Non-Covalent Functionalization of Black Phosphorus (BP) using Perylene Diimide Derivatives for the Passivation of BP Nanosheets (2024) Eisenkolb J, Lloret V, Zink-Lorre N, Pla S, Abellán G, Sastre-Santos Á, Hauke F, et al. Journal article Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): what do we need to know? (2024) Coca-Pelaz A, Rodrigo JP, Agaimy A, Hartl DM, Stenman G, Vander Poorten V, Mäkitie AA, et al. Journal article, Review article Long-Lived Charge Carrier Photogeneration in a Cooperative Supramolecular Double-Cable Polymer (2024) Joseph J, Berrocal JA, Casellas NM, Guldi DM, Torres T, García-Iglesias M Journal article A bending test protocol for characterizing the mechanical performance of flexible photovoltaics (2024) Fukuda K, Sun L, Du B, Takakuwa M, Wang J, Someya T, Marsal LF, et al. Journal article Stiffness-fault-tolerant control strategy for elastic actuators with interaction impedance adaptation (2024) Velasco Guillen RJ, Furnemont R, Verstraten T, Vanderborght B, Font-Llagunes JM, Beckerle P Journal article, Original article Revealing Intrinsic Functionalization, Structure, and Photo-Thermal Oxidation in Hexagonal Antimonene (2024) Alcaraz M, Fickert M, Dolle C, Changarath ME, Sánchez-Royo JF, Eggeler YM, Abellán G Journal article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article